Gene · 2122
Papers2,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of miR-181a-5p and its Target Genes in the Progression of Clear Cell Renal Cell Carcinoma and Association With the Immune Microenvironment. | Clin Genitourin Cancer | 2025 | 40670255 | PubTator, text mining | PubMed |
| hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity. | Gene Ther | 2025 | 40664913 | PubTator, text mining | PubMed |
| PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7. | Hemasphere | 2025 | 40657304 | PubTator, text mining | PubMed |
| Unveiling the Role of Histone Methyltransferases in Psoriasis Pathogenesis: Insights from Transcriptomic Analysis. | Int J Mol Sci | 2025 | 40650108 | PubTator, text mining | PubMed |
| In silico analysis of nicotine's molecular targets in Parkinson's disease. | Xenobiotica | 2025 | 40533911 | PubTator, text mining | PubMed |
| BifurcatoR: A Framework for Revealing Clinically Actionable Signal in Variance Masquerading as Noise. | bioRxiv | 2025 | 40502166 | PubTator, text mining | PubMed |
| Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML. | bioRxiv | 2025 | 40462988 | PubTator, text mining | PubMed |
| What Is Acute Myeloid Leukemia? | EJHaem | 2025 | 40421449 | PubTator, text mining | PubMed |
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| Editorial: Cardiovascular immunometabolism - a complex interplay between the immune system and metabolism in the heart. | Front Endocrinol (Lausanne) | 2025 | 40370780 | PubTator, text mining | PubMed |
| Design principles of cell-state-specific enhancers in hematopoiesis. | Cell | 2025 | 40345201 | PubTator, text mining | PubMed |
| Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature. | Front Oncol | 2025 | 40255434 | PubTator, text mining | PubMed |
| Fate and state transitions during human blood vessel organoid development. | Cell | 2025 | 40250419 | PubTator, text mining | PubMed |
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement. | Front Oncol | 2025 | 40212679 | PubTator, text mining | PubMed |
| RUNX1::MECOM rearrangement in myeloid neoplasm post cytotoxic therapy following sarcoma treatment: a case presentation and review of the literature. | Hematology | 2025 | 40204525 | PubTator, text mining | PubMed |
| Genes predisposing to acute cerebral circulatory failure in severe pre-eclampsia in the Kazakh population. | Int J Gynaecol Obstet | 2025 | 40202699 | PubTator, text mining | PubMed |
| A novel MECOM gene variant causes severe thrombocytopenia in a neonate: a case report and review of the literature. | J Med Case Rep | 2025 | 40170114 | PubTator, text mining | PubMed |
| The Fusion Genes and Their Relation with Genetic Variants in Egyptian AML Patients. | Asian Pac J Cancer Prev | 2025 | 40156426 | PubTator, text mining | PubMed |
| Identification and characterization of human retinal stem cells capable of retinal regeneration. | Sci Transl Med | 2025 | 40138453 | PubTator, text mining | PubMed |
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). | Blood Cancer J | 2025 | 40118819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2122/papers?page=5